BIOXCEL THERAPEUTICS INC (BTAI)
US09075P1057 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 380K | 1.38M 263.16% | 3.191M 131.23% | 4.652M 45.79% | 15.486M 232.89% | 58.854M 280.05% | 108.68M 84.66% | 169.47M 55.93% | 84.66M -50.04% | 139.54M 64.82% | 199.41M 42.91% | ||
| EBITDA YoY % growth | -106.64M -29.87% | -159.32M -49.40% | -167.301M -5.01% | -74.797M 55.29% | -82.245M -9.96% | -69.768M 15.17% | -32.079M 54.02% | 1.785M 105.56% | 49.419M 2,668.57% | 11.526M -76.68% | 59.16M 413.27% | 111.28M 88.10% | |
| EBIT YoY % growth | -106.94M -29.94% | -159.65M -49.29% | -167.619M -4.99% | -76.724M 54.23% | -75.663M 1.38% | -60.739M 19.72% | -34.629M 42.99% | 1.224M 103.53% | 48.807M 3,887.50% | 11.016M -77.43% | 58.446M 430.56% | 110.36M 88.82% | |
| Operating Margin | N/A | -42,013.16% | -12,146.30% | -2,404.38% | -1,626.47% | -392.22% | -58.84% | 1.13% | 28.80% | 13.01% | 41.88% | 55.34% | |
| EPS YoY % growth | -4.08 -7.65% | -5.91 -44.90% | -6.15 -4.03% | -1.86 69.81% | -1.59 14.29% | -1.13 29.17% | -0.87 23.08% | -0.05 94.12% | 0.38 840.00% | 2.69 613.51% | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.52 32.22% | -0.48 44.90% | -0.47 -125.86% | -0.44 -38.66% | -0.38 25.74% |
| Revenue Q2Q % growth | 1.362M 262.23% | 1.326M 127.84% | 1.428M 29.35% | 1.53M 614.95% | 1.734M 27.31% |
| EBITDA Q2Q % growth | -18.574M 5.03% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -18.744M 5.69% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.32 81.40% | -0.55 | 0.23 | 42.08% |
| Q2 2024 Q2Q % growth | -0.21 88.52% | -0.72 | 0.51 | 71.00% |
| Q1 2024 Q2Q % growth | -0.87 52.72% | -0.71 | -0.16 | -22.14% |
| Q4 2023 Q2Q % growth | -0.76 61.03% | -0.93 | 0.17 | 18.12% |
| Q3 2023 Q2Q % growth | -1.72 -15.28% | -1.33 | -0.39 | -29.32% |
| Q2 2023 Q2Q % growth | -1.83 -35.56% | -1.79 | -0.04 | -2.47% |
| Q1 2023 Q2Q % growth | -1.84 -64.29% | -1.65 | -0.19 | -11.48% |
| Q4 2022 Q2Q % growth | -1.95 -109.68% | -1.48 | -0.47 | -32.18% |
| Q3 2022 Q2Q % growth | -1.49 -55.42% | -1.38 | -0.11 | -8.35% |
| Q2 2022 Q2Q % growth | -1.35 -21.62% | -1.24 | -0.11 | -8.57% |
| Q1 2022 Q2Q % growth | -1.12 -3.70% | -1.17 | 0.05 | 4.24% |
| Q4 2021 Q2Q % growth | -0.93 -6.90% | -1.13 | 0.20 | 17.41% |
| Q3 2021 Q2Q % growth | -0.96 10.28% | -1.07 | 0.11 | 10.45% |
| Q2 2021 Q2Q % growth | -1.11 -4.72% | -1.11 | 0.00 | -0.30% |
| Q1 2021 Q2Q % growth | -1.08 -36.71% | -0.96 | -0.12 | -12.79% |
| Q4 2020 Q2Q % growth | -0.87 -93.33% | -0.98 | 0.11 | 10.87% |
| Q3 2020 Q2Q % growth | -1.07 -87.72% | -0.81 | -0.26 | -31.31% |
| Q2 2020 Q2Q % growth | -1.06 -96.30% | -0.76 | -0.30 | -38.77% |
| Q1 2020 Q2Q % growth | -0.79 -71.74% | -0.61 | -0.18 | -30.17% |
| Q4 2019 Q2Q % growth | -0.45 | -0.65 | 0.20 | 30.34% |
| Q3 2019 Q2Q % growth | -0.57 | -0.66 | 0.09 | 13.58% |
| Q2 2019 Q2Q % growth | -0.54 | -0.62 | 0.08 | 12.35% |
| Q1 2019 Q2Q % growth | -0.46 | -0.56 | 0.10 | 17.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 214K -37.24% | 1.332M | -1.118M | -83.93% |
| Q2 2024 Q2Q % growth | 1.104M 141.58% | 774.384K | 329.616K | 42.56% |
| Q1 2024 Q2Q % growth | 582K 182.52% | 473.28K | 108.72K | 22.97% |
| Q4 2023 Q2Q % growth | 376K 56.67% | 725.353K | -349.353K | -48.16% |
| Q3 2023 Q2Q % growth | 341K 143.57% | 673.2K | -332.2K | -49.35% |
| Q2 2023 Q2Q % growth | 457K | 462.968K | -5.968K | -1.29% |
| Q1 2023 Q2Q % growth | 206K | 509.072K | -303.072K | -59.53% |
| Q4 2022 Q2Q % growth | 240K | 1.273M | -1.033M | -81.15% |
| Q3 2022 Q2Q % growth | 140K | 1.116M | -976K | -87.46% |
| Q1 2022 Q2Q % growth | 127.5K | -127.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 16.94% | 7.54% | 7.61% |
| Revenue | 0% | 31.59% | -21.13% | -34.6% |